Patents for A61P 19 - Drugs for skeletal disorders (81,981)
02/1996
02/28/1996EP0697890A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent
02/28/1996EP0697873A1 Olefin-substituted long chain compounds
02/28/1996CN1117735A Steroids for treating menopausal complaints
02/27/1996US5494907 11-β substituted-19-nor steroids
02/27/1996US5494906 Treating metabolic bone disease
02/22/1996WO1996005164A1 Anti-inflammatory preparation
02/22/1996CA2196422A1 Anti-inflammatory preparation
02/21/1996EP0697408A1 1 substituted-phenyl-oxazolidene-2-one derivatives and their use as adhesion-receptor antagonists
02/21/1996EP0588797B1 N- 4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections
02/21/1996EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha
02/21/1996CN1116940A Medicinal composite for rheumatism
02/20/1996US5492922 Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation
02/20/1996CA1338077C Heterodimeric transforming growth factor-beta
02/15/1996WO1996003999A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof
02/15/1996WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives
02/15/1996CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives
02/14/1996CN1116628A Cyclopeptides of the formulal
02/14/1996CN1116529A Method for preparing "Jingluotong" medicine for clearing and activating channels and collaterals
02/13/1996CA2035841C Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
02/08/1996WO1996003385A1 3,4-substituted pyrazoles for the treatment of inflammation
02/08/1996WO1995022611A3 Methods and compositions for stimulating bone cells
02/08/1996CA2195123A1 3,4-substituted pyrazoles for the treatment of inflammation
02/01/1996WO1996002565A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
02/01/1996WO1996002507A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
02/01/1996WO1996002259A1 Hard tissue stimulating agent
02/01/1996CA2195474A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
02/01/1996CA2191975A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
01/1996
01/31/1996EP0694561A1 Calcitonin analogue and use thereof
01/31/1996EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
01/31/1996EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
01/30/1996US5488058 Urogenital disorders or osteoporosis
01/25/1996WO1996001825A1 Heterobicyclic derivatives
01/25/1996WO1996001653A1 Methods and compositions for the specific coagulation of vasculature
01/25/1996CA2194872A1 Pyridopyrazine derivatives
01/24/1996EP0693285A2 Pharmaceutical compositions containing a bisphosphonate and an anti-resorptive agent for inhibiting bone loss
01/24/1996EP0692965A1 Method and composition for treatment of osteoporosis
01/24/1996EP0451216B1 Humanized immunoglobulins and their production and use
01/24/1996CN1115240A Pill for stimulating circulation of blood and causing muscles and joints to relax
01/23/1996US5486534 3,4-substituted pyrazoles for the treatment of inflammation
01/23/1996CA2154414A1 Combination treatment for inhibiting bone loss
01/23/1996CA2154403A1 A novel osteoblast proliferative factor
01/23/1996CA1337972C Agent for treating hyperuricemia
01/17/1996EP0691849A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d
01/17/1996EP0691814A1 Method and composition for treatment of osteoporosis
01/17/1996EP0602028B1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them
01/17/1996EP0554381B1 Use of protective agents against reactive oxygen species
01/17/1996CN1114886A Bones and tendon recovery cream
01/16/1996US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins
01/16/1996US5484797 Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis
01/16/1996US5484796 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell proliferation
01/16/1996US5484795 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis
01/11/1996WO1996000730A1 Vitronectin receptor antagonists
01/11/1996WO1996000574A1 Vitronectin receptor antagonists
01/11/1996CA2193966A1 Vitronectin receptor antagonists
01/10/1996EP0691129A2 Thiazolidone and pyrrolidinone compounds for inhibiting bone loss
01/10/1996EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
01/10/1996EP0690871A1 Growth differentiation factor-5
01/10/1996EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products
01/10/1996EP0690719A1 Dry mix formulation for bisphosphonic acids
01/10/1996EP0394429B1 Preparation for transdermal application containing gestodene
01/09/1996US5482949 Inhibiting bone loss, lowering cholesterol levels, and treating estrogen dependent mammary or uterine carcinoma
01/09/1996CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use
01/07/1996CA2153213A1 Methods of inhibiting bone loss
01/04/1996WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
01/03/1996EP0689544A1 Process for production of an imidazole derivative
01/03/1996CN1030609C Methylenebisphosphonic acid derivatives
01/02/1996US5480873 Arthritis
12/1995
12/27/1995EP0688787A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration
12/27/1995EP0688360A1 Bone stimulating factor
12/27/1995EP0688214A1 Methods for inhibiting bone loss with 3,4-diarylchroman
12/27/1995EP0688211A1 Methods and compositions for inhibition of angiogenesis
12/26/1995US5478955 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26, 27-dimethylene-24-epi-1α, 25-dihydroxyvitamin D2 and methods for preparing same
12/26/1995US5478847 Methods of use for inhibiting bone loss and lowering serum cholesterol
12/20/1995EP0687470A2 Agents for treating metabolic bone diseases
12/20/1995EP0687270A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them
12/19/1995US5476866 Isoxazoles
12/19/1995US5476865 Methods of inhibiting bone loss
12/18/1995CA2152023A1 Agents for treating metabolic bone diseases
12/14/1995WO1995033830A1 Bmp-9 compositions
12/14/1995WO1995033763A1 Novel elastase inhibitors
12/14/1995WO1995033762A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
12/14/1995WO1995033466A1 Pyridylbisphosphonates for use as a therapeutical agent
12/13/1995EP0686037A1 Hormone replacement therapy
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/07/1995WO1995032710A1 Compounds for inhibiting osteoclast-mediated bone resorption
12/07/1995WO1995032623A1 Meniscal augmentation device
12/07/1995CA2190870A1 Compounds for inhibiting osteoclast-mediated bone resorption
12/06/1995EP0684827A1 USE OF 26,26,26,27,27,27-HEXAFLUORO-1$g(a),25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS
11/1995
11/29/1995EP0684241A1 N-pyridyl carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
11/29/1995EP0684240A1 Hydroxamic acid derivatives with tricyclic substitution
11/29/1995CN1112421A Estradiol weekly-acting percutaneous absorption adhesive plaster
11/29/1995CN1112420A Orally administerable pharmaceutical formulations
11/28/1995US5470952 Interleukin antagonists
11/23/1995WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE
11/23/1995WO1995031203A1 Oral liquid alendronate formulations
11/22/1995EP0683173A1 Cyclic adhesion inhibitors
11/22/1995EP0683156A1 Acylated aminoalkanimidazoles and -triazoles
11/22/1995EP0682672A1 Steroids for treating menopausal complaints
11/22/1995CN1112104A Acetic acid derivatives